Clinical Trial Update: Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs

View source ↗

Summary

This clinical trial update reports dynamic changes in monocytes and natural killer cells in a chronic hepatitis C patient treated with direct-acting antivirals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Direct-acting antivirals (DAAs)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Chronic Hepatitis C (Disorder) | Status: COMPLETED